148 related articles for article (PubMed ID: 34191365)
1. Further evidence for the benefit of therapeutic plasma exchange for acute multi-organ failure syndrome refractory to red cell exchange in sickle cell disease.
Siddiqui RS; Ferman DA; Shi PA
J Clin Apher; 2021 Oct; 36(5):777-779. PubMed ID: 34191365
[TBL] [Abstract][Full Text] [Related]
2. Case series supporting heme detoxification via therapeutic plasma exchange in acute multiorgan failure syndrome resistant to red blood cell exchange in sickle cell disease.
Louie JE; Anderson CJ; Fayaz M Fomani K; Henry A; Killeen T; Mohandas N; Yazdanbakhsh K; Belcher JD; Vercellotti GM; Shi PA
Transfusion; 2018 Feb; 58(2):470-479. PubMed ID: 29193101
[TBL] [Abstract][Full Text] [Related]
3. Successful therapeutic plasma exchange for a patient with sickle cell disease and fat embolism syndrome after a failure of a response to red cell exchange transfusion.
Alsaghir A; Alsaghir L; Alsaif J; Mobeireek A
Transfusion; 2023 Feb; 63 Suppl 1():S33-S36. PubMed ID: 36748667
[TBL] [Abstract][Full Text] [Related]
4. Reversal of Severe Multiorgan Failure Associated With Sickle Cell Crisis Using Plasma Exchange: A Case Series.
Zaidi GZ; Rosentsveyg JA; Fomani KF; Louie JP; Koenig SJ
J Intensive Care Med; 2020 Feb; 35(2):140-148. PubMed ID: 31476954
[TBL] [Abstract][Full Text] [Related]
5. Plasma exchange in critically ill patients with sickle cell disease.
Boga C; Kozanoglu I; Ozdogu H; Ozyurek E
Transfus Apher Sci; 2007 Aug; 37(1):17-22. PubMed ID: 17707694
[TBL] [Abstract][Full Text] [Related]
6. Plasma exchange-A useful adjunct therapy to red cell exchange in patients with sickle cell disease and multiorgan dysfunction.
Webb CB; Yates SG; Sarode R; Kim J
Transfusion; 2023 Jul; 63(7):1384-1390. PubMed ID: 37317564
[TBL] [Abstract][Full Text] [Related]
7. Reversal of multiorgan system dysfunction in sickle cell disease with plasma exchange.
Geigel EJ; Francis CW
Acta Anaesthesiol Scand; 1997 May; 41(5):647-50. PubMed ID: 9181170
[TBL] [Abstract][Full Text] [Related]
8. Sicklemia with multi-organ failure syndrome and thrombotic thrombocytopenic purpura.
Chehal A; Taher A; Shamseddine A
Hemoglobin; 2002 Nov; 26(4):345-51. PubMed ID: 12484629
[TBL] [Abstract][Full Text] [Related]
9. Red cell exchange in sickle cell disease.
Swerdlow PS
Hematology Am Soc Hematol Educ Program; 2006; ():48-53. PubMed ID: 17124039
[TBL] [Abstract][Full Text] [Related]
10. Comparison of automated red cell exchange transfusion and simple transfusion for the treatment of children with sickle cell disease acute chest syndrome.
Saylors RL; Watkins B; Saccente S; Tang X
Pediatr Blood Cancer; 2013 Dec; 60(12):1952-6. PubMed ID: 24000077
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic plasma exchange in pediatric intensive care: Indications, results and complications.
Sık G; Demirbuga A; Annayev A; Akcay A; Çıtak A; Öztürk G
Ther Apher Dial; 2020 Apr; 24(2):221-229. PubMed ID: 31922326
[TBL] [Abstract][Full Text] [Related]
12. Effect of red cell exchange transfusion on plasma levels of inflammatory mediators in sickle cell patients with acute chest syndrome.
Liem RI; O'Gorman MR; Brown DL
Am J Hematol; 2004 May; 76(1):19-25. PubMed ID: 15114592
[TBL] [Abstract][Full Text] [Related]
13. Red cell exchange for patients with sickle cell disease: an international survey of current practices.
Karafin MS; Hendrickson JE; Kim HC; Kuliya-Gwarzo A; Pagano MB; Perumbeti A; Shi PA; Tanhehco YC; Webb J; Wong E; Eichbaum Q
Transfusion; 2020 Jul; 60(7):1424-1433. PubMed ID: 32583456
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic plasma exchange in the management of acute complications of sickle cell disease: A single centre experience.
Tsitsikas DA; Mihalca D; Hibbs S; Freeman T; Bello-Sanyaolu O; Orebayo F; Lewis N; Green L
Transfus Apher Sci; 2022 Jun; 61(3):103375. PubMed ID: 35131182
[TBL] [Abstract][Full Text] [Related]
15. The therapeutic efficacy of adjunct therapeutic plasma exchange for septic shock with multiple organ failure: a single-center experience.
Keith PD; Wells AH; Hodges J; Fast SH; Adams A; Scott LK
Crit Care; 2020 Aug; 24(1):518. PubMed ID: 32831133
[TBL] [Abstract][Full Text] [Related]
16. Crises in Sickle Cell Disease.
Novelli EM; Gladwin MT
Chest; 2016 Apr; 149(4):1082-93. PubMed ID: 26836899
[TBL] [Abstract][Full Text] [Related]
17. Thrombotic microangiopathy in sickle cell disease crisis.
Shome DK; Ramadorai P; Al-Ajmi A; Ali F; Malik N
Ann Hematol; 2013 Apr; 92(4):509-15. PubMed ID: 23224266
[TBL] [Abstract][Full Text] [Related]
18. Transfusion-transmitted malaria masquerading as sickle cell crisis with multisystem organ failure.
Maier CL; Gross PJ; Dean CL; Chonat S; Ip A; McLemore M; El Rassi F; Stowell SR; Josephson CD; Fasano RM
Transfusion; 2018 Jun; 58(6):1550-1554. PubMed ID: 29524230
[TBL] [Abstract][Full Text] [Related]
19. Effects of repleting organic phosphates in banked erythrocytes on plasma metabolites and vasoactive mediators after red cell exchange transfusion in sickle cell disease.
Lopez Domowicz DA; Welsby I; Esther CR; Zhu H; Marek RD; Lee G; Shah N; Poisson JL; McMahon TJ
Blood Transfus; 2020 May; 18(3):200-207. PubMed ID: 32203007
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of recurrent hyperhemolysis syndrome with immunosuppression and plasma-to-red blood cell exchange transfusion.
Uhlmann EJ; Shenoy S; Goodnough LT
Transfusion; 2014 Feb; 54(2):384-8. PubMed ID: 23692505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
